Herantis Pharma Oyj
HRTIS
Rank in Stocks
#23483
Herantis Pharma Oyj, a biotechnology company founded in Espoo, Finland, in... Herantis Pharma Oyj, a biotechnology company founded in Espoo, Finland, in 2008, is dedicated to developing innovative, disease-modifying CDNF-based treatments for Parkinson's disease (PD). Its pipeline features two key assets: HER-096, an advanced small, synthetic chemical peptidomimetic (a modified version of the active CDNF parent molecule) which is in preclinical stages as an xCDNF candidate for Parkinson's and other neurodegenerative conditions; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein currently in Phase I clinical trials for patients with PD.
Share Price
$1.54
Last synced: 2026-11-18
Market Cap
$39.79M
Change (1 day)
3.57%
Change (1 year)
-37.37%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Herantis Pharma Oyj (HRTIS)
Category
Healthcare
Operating Margin for Herantis Pharma Oyj (HRTIS)
Operating Margin as of November 2026 TTM: 0.00%
According to Herantis Pharma Oyj's latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Herantis Pharma Oyj from 2011 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | -100.00% |
| 2016 | -17,477.28% | -97.89% |
| 2015 | -826,905.37% | -13.61% |
| 2014 | -957,125.00% | 0.00% |
| 2013 | 0.00% | -100.00% |
| 2012 | -965,677.45% | 0.00% |
| 2011 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| -195.39% | - |
US
|
|
| 33.87% | - |
US
|
|
| -116.04% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Herantis Pharma Oyj's operating margin
What was Herantis Pharma Oyj's operating margin in 2025?
In 2025, Herantis Pharma Oyj's operating margin was 0.00%, compared with 0.00% in 2024.
How has Herantis Pharma Oyj's operating margin changed since 2020?
From 2020 to 2025, Herantis Pharma Oyj's operating margin was highest in 2025 (0.00%) and lowest in 2025 (0.00%).
How does Herantis Pharma Oyj's operating margin compare with similar companies?
Herantis Pharma Oyj's operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.